| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
GSE162338
|
SRA Run Selector
|
May 16, 2022
|
||||||
| GSM4911338 |
ETV6-NCOA2 CD34
|
SRA | 1 |
|
|
Gilgi Friedlander | May 16, 2022 | ||
| GSM4911339 |
ETV6-NCOA2 CD34_control
|
SRA | 1 |
|
|
Gilgi Friedlander | May 16, 2022 | ||
| GSM4911340 |
Empty vector CD34
|
SRA | 1 |
|
|
Gilgi Friedlander | May 16, 2022 | ||
| GSM4911341 |
Empty vector CD34_control
|
SRA | 1 |
|
|
Gilgi Friedlander | May 16, 2022 | ||
| GSM4911342 |
ETV6-NCOA2 patient-derived xenograft
|
SRA | 1 |
|
|
Gilgi Friedlander | May 16, 2022 | ||
| GSM4911343 |
ETV6-NCOA2 patient-derived xenograft_control
|
SRA | 1 |
|
|
Gilgi Friedlander | May 16, 2022 | ||
| GSM4912892 |
ETV6-NCOA2 patient derived xenograft_1 [EN2_PDX_3]
|
SRA | 1 |
|
|
Gilgi Friedlander | May 16, 2022 | ||
| GSM4912893 |
ETV6-NCOA2 patient derived xenograft_2 [EN2_PDX_1]
|
SRA | 1 |
|
|
Gilgi Friedlander | May 16, 2022 | ||
| GSM4912894 |
ETV6-NCOA2 patient derived xenograft_3 [EN2_PDX_2]
|
SRA | 1 |
|
|
Gilgi Friedlander | May 16, 2022 | ||
| GSM4912895 |
ETV6-NCOA2+NOTCH1-L1601PdP_1 [EN2+N_5]
|
SRA | 1 |
|
|
Gilgi Friedlander | May 16, 2022 | ||
| GSM4912896 |
ETV6-NCOA2+NOTCH1-L1601PdP_2 [EN2+N_4]
|
SRA | 1 |
|
|
Gilgi Friedlander | May 16, 2022 | ||
| GSM4912897 |
ETV6-NCOA2+NOTCH1-L1601PdP_3 [EN2+N_3]
|
SRA | 1 |
|
|
Gilgi Friedlander | May 16, 2022 | ||
| GSM4912898 |
ETV6-NCOA2+NOTCH1-L1601PdP_4 [EN2+N_1]
|
SRA | 1 |
|
|
Gilgi Friedlander | May 16, 2022 | ||
| GSM4912899 |
ETV6-NCOA2+NOTCH1-L1601PdP_5 [EN2+N_2]
|
SRA | 1 |
|
|
Gilgi Friedlander | May 16, 2022 | ||
| GSM4912900 |
ETV6-NCOA2_1 [EN2_2]
|
SRA | 1 |
|
|
Gilgi Friedlander | May 16, 2022 | ||
| GSM4912901 |
ETV6-NCOA2_2 [EN2_3]
|
SRA | 1 |
|
|
Gilgi Friedlander | May 16, 2022 | ||
| GSM4912902 |
ETV6-NCOA2_3 [EN2_1]
|
SRA | 1 |
|
|
Gilgi Friedlander | May 16, 2022 | ||
| GSM4912903 |
ETV6-NCOA2_in-vitro_1 [EN2_in_vitro_1]
|
SRA | 1 |
|
|
Gilgi Friedlander | May 16, 2022 | ||
| GSM4912904 |
ETV6-NCOA2_in-vitro_2 [EN2_in_vitro_2]
|
SRA | 1 |
|
|
Gilgi Friedlander | May 16, 2022 | ||
| GSM4912905 |
ETV6-NCOA2_in-vitro_3 [EN2_in_vitro_3]
|
SRA | 1 |
|
|
Gilgi Friedlander | May 16, 2022 |
